JP2022536901A5 - - Google Patents
Info
- Publication number
- JP2022536901A5 JP2022536901A5 JP2021573420A JP2021573420A JP2022536901A5 JP 2022536901 A5 JP2022536901 A5 JP 2022536901A5 JP 2021573420 A JP2021573420 A JP 2021573420A JP 2021573420 A JP2021573420 A JP 2021573420A JP 2022536901 A5 JP2022536901 A5 JP 2022536901A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloalkyl
- group
- substituents
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962860676P | 2019-06-12 | 2019-06-12 | |
| US62/860,676 | 2019-06-12 | ||
| US201962943666P | 2019-12-04 | 2019-12-04 | |
| US62/943,666 | 2019-12-04 | ||
| PCT/US2020/037309 WO2020252205A1 (en) | 2019-06-12 | 2020-06-11 | Inhibitors of integrated stress response pathway |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022536901A JP2022536901A (ja) | 2022-08-22 |
| JP2022536901A5 true JP2022536901A5 (cg-RX-API-DMAC10.html) | 2023-06-19 |
Family
ID=73781542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573420A Pending JP2022536901A (ja) | 2019-06-12 | 2020-06-11 | 統合的ストレス応答経路の阻害剤 |
Country Status (12)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021508336A (ja) | 2017-12-13 | 2021-03-04 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路の阻害剤 |
| US11166942B2 (en) | 2018-06-05 | 2021-11-09 | Praxis Biotech LLC | Inhibitors of integrated stress response pathway |
| JP2022536663A (ja) | 2019-06-12 | 2022-08-18 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路のモジュレーター |
| KR20220151635A (ko) | 2020-03-11 | 2022-11-15 | 에보텍 인터내셔널 게엠베하 | 통합 스트레스 반응 경로의 조절제 |
| CA3195290A1 (en) | 2020-10-22 | 2022-04-28 | Holly Victoria Atton | Modulators of the integrated stress response pathway |
| MX2023004677A (es) | 2020-10-22 | 2023-05-24 | Evotec Int Gmbh | Moduladores de la via de respuesta integrada al estres. |
| ES2997335T3 (en) | 2020-10-22 | 2025-02-17 | Evotec Int Gmbh | Modulators of the integrated stress response pathway |
| WO2022256609A1 (en) * | 2021-06-03 | 2022-12-08 | Altos Labs, Inc. | Modulators of integrated stress response pathway |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1403255A4 (en) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | RHO KINASE INHIBITORS |
| US7544690B2 (en) * | 2001-10-01 | 2009-06-09 | Taisho Pharmaceutical Co., Ltd. | MCH receptor antagonists |
| WO2009151800A1 (en) * | 2008-05-07 | 2009-12-17 | Merck & Co., Inc. | Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| US8273900B2 (en) * | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
| EP2531490B1 (en) * | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| WO2014144952A2 (en) * | 2013-03-15 | 2014-09-18 | Peter Walter | Modulators of the eif2alpha pathway |
| TW201808888A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
-
2020
- 2020-06-11 JP JP2021573420A patent/JP2022536901A/ja active Pending
- 2020-06-11 CN CN202080056130.0A patent/CN114206829A/zh active Pending
- 2020-06-11 WO PCT/US2020/037309 patent/WO2020252205A1/en not_active Ceased
- 2020-06-11 MX MX2021015210A patent/MX2021015210A/es unknown
- 2020-06-11 BR BR112021024431A patent/BR112021024431A2/pt not_active Application Discontinuation
- 2020-06-11 CA CA3142497A patent/CA3142497A1/en active Pending
- 2020-06-11 US US16/899,520 patent/US20210317102A1/en not_active Abandoned
- 2020-06-11 KR KR1020227000920A patent/KR20220024486A/ko not_active Withdrawn
- 2020-06-11 AU AU2020293226A patent/AU2020293226A1/en not_active Abandoned
- 2020-06-11 EP EP20821646.5A patent/EP3983378A4/en not_active Withdrawn
-
2021
- 2021-12-06 CL CL2021003247A patent/CL2021003247A1/es unknown
- 2021-12-07 IL IL288747A patent/IL288747A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022536663A5 (cg-RX-API-DMAC10.html) | ||
| JP2022521605A5 (cg-RX-API-DMAC10.html) | ||
| Wrobleski et al. | Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165 | |
| JP2021527044A5 (cg-RX-API-DMAC10.html) | ||
| JP7366456B2 (ja) | インターフェロン遺伝子刺激因子stingのアゴニスト | |
| RU2020122711A (ru) | Ингибиторы пути интегрированной реакции на стресс | |
| JP6666263B2 (ja) | グルタミナーゼの新規阻害剤 | |
| US20240293418A1 (en) | Combination therapy for treating cancer | |
| TWI683825B (zh) | 單鏈trail-受體激動劑蛋白質 | |
| JP2022536901A (ja) | 統合的ストレス応答経路の阻害剤 | |
| US20100113520A1 (en) | Kinase knockdown via electrophilically enhanced inhibitors | |
| JP2022536663A (ja) | 統合的ストレス応答経路のモジュレーター | |
| JP2018113988A (ja) | IL−1βへの結合メンバー | |
| CN108137672B (zh) | 用于生产具有igg fc结构域的融合蛋白的方法 | |
| CA2889756A1 (en) | Thiohydantoin compounds as androgen receptor modulators | |
| JP2021527044A (ja) | 統合的ストレス応答経路の阻害剤 | |
| CN105399685A (zh) | 作为选择性jak3和/或jak1激酶抑制剂的芳杂环化合物的制备方法及其应用 | |
| WO2020033782A1 (en) | Activators of the retinoic acid inducible gene "rig-1" pathway and methods of use thereof | |
| TW202432124A (zh) | 蛋白質酪胺酸磷酸酶抑制劑、其組合物及使用方法 | |
| WO2023192801A1 (en) | Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors | |
| CN113164492A (zh) | 用于治疗癌症的nupr1抑制 | |
| AU2016341402A1 (en) | Single-chain GITR-receptor agonist proteins | |
| Bakherad et al. | Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity | |
| RU2022100043A (ru) | Ингибиторы пути интегрированной реакции на стресс | |
| KR20230022457A (ko) | Akt3 조절제 |